94 related articles for article (PubMed ID: 20944678)
1. Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells.
Kruse U; Pallasch CP; Bantscheff M; Eberhard D; Frenzel L; Ghidelli S; Maier SK; Werner T; Wendtner CM; Drewes G
Leukemia; 2011 Jan; 25(1):89-100. PubMed ID: 20944678
[TBL] [Abstract][Full Text] [Related]
2. The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
Paesler J; Gehrke I; Gandhirajan RK; Filipovich A; Hertweck M; Erdfelder F; Uhrmacher S; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
Clin Cancer Res; 2010 Jul; 16(13):3390-8. PubMed ID: 20570929
[TBL] [Abstract][Full Text] [Related]
3. SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.
Conroy A; Stockett DE; Walker D; Arkin MR; Hoch U; Fox JA; Hawtin RE
Cancer Chemother Pharmacol; 2009 Sep; 64(4):723-32. PubMed ID: 19169685
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction inhibitors in chronic lymphocytic leukemia.
Ma S; Rosen ST
Curr Opin Oncol; 2011 Nov; 23(6):601-8. PubMed ID: 21892084
[TBL] [Abstract][Full Text] [Related]
5. Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia.
Wiernik PH
Expert Opin Investig Drugs; 2016 Jun; 25(6):729-34. PubMed ID: 26998706
[TBL] [Abstract][Full Text] [Related]
6. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
7. The biological rationale and clinical efficacy of inhibition of signaling kinases in chronic lymphocytic leukemia.
de Weerdt I; Eldering E; van Oers MH; Kater AP
Leuk Res; 2013 Jul; 37(7):838-47. PubMed ID: 23597579
[TBL] [Abstract][Full Text] [Related]
8. Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia.
Billard C; Kern C; Tang R; Ajchenbaum-Cymbalista F; Kolb JP
Leukemia; 2003 Dec; 17(12):2435-43. PubMed ID: 14523476
[TBL] [Abstract][Full Text] [Related]
9. p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.
López-Guerra M; Roué G; Pérez-Galán P; Alonso R; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2009 Apr; 15(8):2767-76. PubMed ID: 19351760
[TBL] [Abstract][Full Text] [Related]
10. VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia.
Sher S; Whipp E; Walker J; Zhang P; Beaver L; Williams K; Orwick S; Ravikrishnan J; Walker B; Perry E; Gregory C; Purcell M; Pan A; Yan P; Alinari L; Johnson AJ; Frigault MM; Greer JM; Hamdy A; Izumi R; Mo X; Sampath D; Woyach J; Blachly J; Byrd JC; Lapalombella R
Leukemia; 2023 Feb; 37(2):326-338. PubMed ID: 36376377
[TBL] [Abstract][Full Text] [Related]
11. Flavopiridol in chronic lymphocytic leukemia: a concise review.
Christian BA; Grever MR; Byrd JC; Lin TS
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S179-85. PubMed ID: 19778838
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.
Contri A; Brunati AM; Trentin L; Cabrelle A; Miorin M; Cesaro L; Pinna LA; Zambello R; Semenzato G; Donella-Deana A
J Clin Invest; 2005 Feb; 115(2):369-78. PubMed ID: 15650771
[TBL] [Abstract][Full Text] [Related]
13. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
Moon EY; Lerner A
Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
[TBL] [Abstract][Full Text] [Related]
14. Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent.
Billard C; Menasria F; Quiney C; Faussat AM; Kolb JP
Leuk Res; 2008 May; 32(5):755-60. PubMed ID: 17981326
[TBL] [Abstract][Full Text] [Related]
15. The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules.
Węsierska-Gądek J; Kramer MP
Future Med Chem; 2012 Mar; 4(4):395-424. PubMed ID: 22416772
[TBL] [Abstract][Full Text] [Related]
16. Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals.
Byrd JC; Rai KR; Sausville EA; Grever MR
Semin Oncol; 1998 Feb; 25(1):65-74. PubMed ID: 9482528
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors.
Tavolaro S; Chiaretti S; Messina M; Peragine N; Del Giudice I; Marinelli M; Santangelo S; Mauro FR; Guarini A; Foà R
Leuk Res; 2010 Jun; 34(6):733-41. PubMed ID: 20036005
[TBL] [Abstract][Full Text] [Related]
18. Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment.
Bright SA; Campiani G; Deininger MW; Lawler M; Williams DC; Zisterer DM
Biochem Pharmacol; 2010 Jul; 80(1):31-8. PubMed ID: 20206141
[TBL] [Abstract][Full Text] [Related]
19. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
